TABLE 1.
EBV- and HCMV-specific ELISA reactivity of serum samples from patients with primary EBV infection
| Serum IDa | Heterophile antibodies | Reactivityb in:
|
||||||
|---|---|---|---|---|---|---|---|---|
| Anti-EBV VCA IgM ELISA | Anti-EBV VCA IgG ELISA | Anti-EBV EBNA IgG ELISA | HCMV-IgG ELISA | HCMV-IgM RecELISA 1 | HCMV-IgM RecELISA 2 | HCMV-IgM ConvELISA | ||
| 1 | Positive | R | R | NR | R | NR | R | R |
| 2 | Positive | R | R | NR | R | R | R | R |
| 3 | Positive | R | R | NR | R | R | R | R |
| 4 | Positive | R | R | NR | R | R | R | R |
| 5 | Positive | R | R | NR | NR | R | R | R |
| 6 | Positive | R | R | NR | NR | NR | NR | NR |
| 7 | Positive | R | R | NR | NR | R | R | NR |
| 8 | Positive | R | R | NR | NR | R | R | R |
| 9 | Positive | R | R | NR | NR | R | R | NR |
| 10 | Positive | R | R | NR | NR | R | R | R |
| 11 | Positive | R | R | NR | NR | NR | R | NR |
a
All serum samples were obtained from nonimmunosuppressed individuals with clinical signs of acute IM.
b
All ELISAs were performed with commercially available test kits. Scores were determined according to the instructions of the manufacturers. R, reactive; NR, not reactive.